What is a stock summary page? Click here for an overview.
Business Description
Caplin Point Laboratories Ltd
ISIN : INE475E01026
Compare
Compare
Traded in other countries / regions
524742.India IPO Date
2001-11-26Description
Caplin Point Laboratories Ltd is an India-based pharmaceutical company. It is engaged in the manufacturing and marketing of pharmaceutical products. The company's key products include tablets, capsules, injections (liquid and lyophilized, prefilled syringes), ophthalmic solutions, liquid orals, soft gel capsules, ointments, creams, gels, powders for injections, suppositories, ovules, pre-mix bag formulations, inhalers, sprays, and IV infusions. It also provides pharmaceutical formulations in specialized injectable dosage forms and Ophthalmic drops.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 359.51 | |||||
| Equity-to-Asset | 0.87 | |||||
| Interest Coverage | 952.03 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 25.79 | |||||
| Beneish M-Score | -1.84 | |||||
| WACC vs ROIC | ||||||
Growth Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 17 | |||||
| 3-Year EBITDA Growth Rate | 20.7 | |||||
| 3-Year EPS without NRI Growth Rate | 23.6 | |||||
| 3-Year FCF Growth Rate | -4 | |||||
| 3-Year Book Growth Rate | 24.8 | |||||
| Future 3-5Y EPS without NRI Growth Rate Estimate | 16.65 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 15.02 |
Momentum Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.95 | |||||
| 9-Day RSI | 50.25 | |||||
| 14-Day RSI | 48.98 | |||||
| 3-1 Month Momentum % | 5.5 | |||||
| 6-1 Month Momentum % | 11.13 | |||||
| 12-1 Month Momentum % | 48.29 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.07 | |||||
| Quick Ratio | 5.07 | |||||
| Cash Ratio | 2.65 | |||||
| Days Inventory | 163.06 | |||||
| Days Sales Outstanding | 105.33 | |||||
| Days Payable | 94.36 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 0.27 | |||||
| Dividend Payout Ratio | 0.07 | |||||
| 3-Year Dividend Growth Rate | 124.1 | |||||
| Forward Dividend Yield % | 0.27 | |||||
| 5-Year Yield-on-Cost % | 0.62 | |||||
| 3-Year Average Share Buyback Ratio | -0.1 | |||||
| Shareholder Yield % | 0.29 |
Profitability Rank
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 59.05 | |||||
| Operating Margin % | 30.02 | |||||
| Net Margin % | 27.54 | |||||
| FCF Margin % | 9.22 | |||||
| ROE % | 22.3 | |||||
| ROA % | 19.24 | |||||
| ROIC % | 27.05 | |||||
| 3-Year ROIIC % | 20.93 | |||||
| ROC (Joel Greenblatt) % | 50.79 | |||||
| ROCE % | 27.4 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 28.27 | |||||
| Forward PE Ratio | 23.52 | |||||
| PE Ratio without NRI | 28.37 | |||||
| Shiller PE Ratio | 48.39 | |||||
| Price-to-Owner-Earnings | 43.68 | |||||
| PEG Ratio | 1.46 | |||||
| PS Ratio | 7.79 | |||||
| PB Ratio | 5.7 | |||||
| Price-to-Tangible-Book | 5.73 | |||||
| Price-to-Free-Cash-Flow | 84.32 | |||||
| Price-to-Operating-Cash-Flow | 45.7 | |||||
| EV-to-EBIT | 21.12 | |||||
| EV-to-EBITDA | 19.18 | |||||
| EV-to-Revenue | 7.29 | |||||
| EV-to-FCF | 75.28 | |||||
| Price-to-GF-Value | 1.43 | |||||
| Price-to-Projected-FCF | 4.37 | |||||
| Price-to-DCF (Earnings Based) | 1.09 | |||||
| Price-to-DCF (FCF Based) | 8.47 | |||||
| Price-to-Median-PS-Value | 1.43 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.43 | |||||
| Price-to-Graham-Number | 2.75 | |||||
| Price-to-Net-Current-Asset-Value | 8.96 | |||||
| Price-to-Net-Cash | 29.46 | |||||
| Earnings Yield (Greenblatt) % | 4.74 | |||||
| FCF Yield % | 1.19 | |||||
| Forward Rate of Return (Yacktman) % | 19.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Caplin Point Laboratories Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 18,709.2 | ||
| EPS (TTM) (₹) | 67.45 | ||
| Beta | 0.93 | ||
| 3-Year Sharpe Ratio | 1.07 | ||
| 3-Year Sortino Ratio | 2 | ||
| Volatility % | 41 | ||
| 14-Day RSI | 48.98 | ||
| 14-Day ATR (₹) | 95.248732 | ||
| 20-Day SMA (₹) | 1920.58 | ||
| 12-1 Month Momentum % | 48.29 | ||
| 52-Week Range (₹) | 1221 - 2636 | ||
| Shares Outstanding (Mil) | 76.01 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Caplin Point Laboratories Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Caplin Point Laboratories Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| No Event Data | ||||
Caplin Point Laboratories Ltd Frequently Asked Questions
What is Caplin Point Laboratories Ltd(BOM:524742)'s stock price today?
The current price of BOM:524742 is ₹1906.80. The 52 week high of BOM:524742 is ₹2636.00 and 52 week low is ₹1221.00.
When is next earnings date of Caplin Point Laboratories Ltd(BOM:524742)?
The next earnings date of Caplin Point Laboratories Ltd(BOM:524742) is .
Does Caplin Point Laboratories Ltd(BOM:524742) pay dividends? If so, how much?
The Dividend Yield %  of Caplin Point Laboratories Ltd(BOM:524742) is 0.27% (As of Today), Highest Dividend Payout Ratio of Caplin Point Laboratories Ltd(BOM:524742) was 0.16. The lowest was 0.01. And the median was 0.08. The  Forward Dividend Yield % of Caplin Point Laboratories Ltd(BOM:524742) is 0.27%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers